MedTrace Logo

Metabolomics Characterization of Biomarkers of ASCVD and Prediction Model

NCT05148182 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1869

Last updated 2021-12-08

No results posted yet for this study

Summary

1. Describe the risk factors and metabonomics characteristics of atherosclerotic cardiovascular disease in Chinese patients.
2. Establish accurate prediction model of atherosclerotic heart disease.

Conditions

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2024-12-15
Completion
2024-12-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05148182 on ClinicalTrials.gov